HIV

June 25, 2019June 25, 2019

Keytruda Found to be Safe as Cancer Treatment for HIV Patients, Phase 1 Trial Shows

News

The immune checkpoint inhibitor Keytruda (pembrolizumab) was found to be a safe treatment for different cancer types among people living with HIV, data from a Phase 1 trial show. The results are ... Read more

March 13, 2019

Immune Checkpoint Inhibitors Safe, Effective in HIV-positive Patients with Advanced Cancer, Research Reveals

News

Immune checkpoint inhibitors may be safe and effective in advanced cancer patients with human immunodeficiency virus (HIV), according to a review study. The research, “Safety and Efficacy of Immune Checkpoint Inhibitor Therapy in Patients ... Read more

November 28, 2018

Opdivo Cancer Treatment Safe for HIV Patients on Antiretrovirals, Study Suggests

News

Patients with human immunodeficiency virus (HIV) may safely receive immune checkpoint inhibitors as a cancer treatment, as long as they continue taking antiretroviral therapies, a retrospective study shows. Findings from ... Read more

December 13, 2016

Tiny Implantable Device Could Transform Delivery of Medications for Cancer, Other Diseases

News

An implantable device could transform the delivery of different medications, including immunotherapy drugs for cancer patients, by removing the need for daily pills or injections, according to a study. The study, ... Read more

July 19, 2016July 19, 2016

Rejiggered Immunotherapy, CAR T-Cells, Able to Halt HIV Spread in Lab Tests

News

The recent discovery of a new group of antibodies allowed researchers at the University of California, Los Angeles (UCLA), to engineer an immunotherapy with promise as a cancer treatment, CAR T-cell therapy, to be used ... Read more

December 23, 2014December 23, 2014

Endogenous Retroviruses Linked to Benefic Immune Responses

News

UT Southwestern Medical Center researchers, in collaboration with colleagues from the Karolinska Institutet in Stockholm, Sweden, have published the results of a recent study in Science, titled “MAVS, cGAS, and ... Read more

August 28, 2014August 28, 2014

Low Dose Naltrexone-based Lodonal Ships to Panama, Malawi For Cancer Treatment

News

TNI BioTech Inc., a biotechnology company developing innovative therapies for autoimmune diseases in emerging nations, has announced it will make its first shipments of Lodonal® to the Republic of Panama ... Read more